A healthful plant-based diet is associated with lower type 2 diabetes risk via improved metabolic state and organ function: A prospective cohort study
CONCLUSION: Healthful plant-based diets may protect against T2DM via lower body fatness, but also via normoglycaemia, lower basal inflammation as well as improved kidney and liver function.PMID:38036055 | DOI:10.1016/j.diabet.2023.101499 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 30, 2023 Category: Endocrinology Authors: Alysha S Thompson Catharina J Candussi Anna Tresserra-Rimbau Amy Jennings Nicola P Bondonno Claire Hill Solomon A Sowah Aed ín Cassidy Tilman K ühn Source Type: research
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes
CONCLUSION: SGLT2is increase overall survival and cancer-specific survival in patients with cancer in a dose-dependent manner.PMID:38036054 | DOI:10.1016/j.diabet.2023.101500 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 30, 2023 Category: Endocrinology Authors: Yen-Min Huang Wan-Ming Chen An-Tzu Jao Mingchih Chen Ben-Chang Shia Szu-Yuan Wu Source Type: research
A healthful plant-based diet is associated with lower type 2 diabetes risk via improved metabolic state and organ function: A prospective cohort study
CONCLUSION: Healthful plant-based diets may protect against T2DM via lower body fatness, but also via normoglycaemia, lower basal inflammation as well as improved kidney and liver function.PMID:38036055 | DOI:10.1016/j.diabet.2023.101499 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 30, 2023 Category: Endocrinology Authors: Alysha S Thompson Catharina J Candussi Anna Tresserra-Rimbau Amy Jennings Nicola P Bondonno Claire Hill Solomon A Sowah Aed ín Cassidy Tilman K ühn Source Type: research
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes
CONCLUSION: SGLT2is increase overall survival and cancer-specific survival in patients with cancer in a dose-dependent manner.PMID:38036054 | DOI:10.1016/j.diabet.2023.101500 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 30, 2023 Category: Endocrinology Authors: Yen-Min Huang Wan-Ming Chen An-Tzu Jao Mingchih Chen Ben-Chang Shia Szu-Yuan Wu Source Type: research
A healthful plant-based diet is associated with lower type 2 diabetes risk via improved metabolic state and organ function: A prospective cohort study
CONCLUSION: Healthful plant-based diets may protect against T2DM via lower body fatness, but also via normoglycaemia, lower basal inflammation as well as improved kidney and liver function.PMID:38036055 | DOI:10.1016/j.diabet.2023.101499 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 30, 2023 Category: Endocrinology Authors: Alysha S Thompson Catharina J Candussi Anna Tresserra-Rimbau Amy Jennings Nicola P Bondonno Claire Hill Solomon A Sowah Aed ín Cassidy Tilman K ühn Source Type: research
French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission- a meta-analysis in patients with class I to III obesity
CONCLUSIONS: . Although the data available in patients with class I obesity and type 2 diabetes remains limited, MA shows higher rates of DR after MS compared with MT after 36 months' follow-up in these patients. Consequently, the French National Authority for Health French (HAS) recommends MS for these patients.PMID:38000504 | DOI:10.1016/j.diabet.2023.101495 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 24, 2023 Category: Endocrinology Authors: Jean-Charles Lafarge Judith Aron-Wisnewsky Fran çois Pattou Michel Cucherat Emmanuelle Blondet Sylvie Lascols Armms Td Consortium Dominique Le Guludec Denis-Jean David C édric Carbonneil Source Type: research
Low frequency of albuminuria testing among diabetic patients in France: Real-world data from clinical laboratories
Diabetes Metab. 2023 Nov 23;50(1):101498. doi: 10.1016/j.diabet.2023.101498. Online ahead of print.NO ABSTRACTPMID:38000505 | DOI:10.1016/j.diabet.2023.101498 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 24, 2023 Category: Endocrinology Authors: Fabrice Bonnet L éa Longepierre Dinh-Phong Nguyen Im ène Sedrati Alegria Marcilla Source Type: research
French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission- a meta-analysis in patients with class I to III obesity
CONCLUSIONS: . Although the data available in patients with class I obesity and type 2 diabetes remains limited, MA shows higher rates of DR after MS compared with MT after 36 months' follow-up in these patients. Consequently, the French National Authority for Health French (HAS) recommends MS for these patients.PMID:38000504 | DOI:10.1016/j.diabet.2023.101495 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 24, 2023 Category: Endocrinology Authors: Jean-Charles Lafarge Judith Aron-Wisnewsky Fran çois Pattou Michel Cucherat Emmanuelle Blondet Sylvie Lascols Armms Td Consortium Dominique Le Guludec Denis-Jean David C édric Carbonneil Source Type: research
Low frequency of albuminuria testing among diabetic patients in France: Real-world data from clinical laboratories
Diabetes Metab. 2023 Nov 23;50(1):101498. doi: 10.1016/j.diabet.2023.101498. Online ahead of print.NO ABSTRACTPMID:38000505 | DOI:10.1016/j.diabet.2023.101498 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 24, 2023 Category: Endocrinology Authors: Fabrice Bonnet L éa Longepierre Dinh-Phong Nguyen Im ène Sedrati Alegria Marcilla Source Type: research
French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission- a meta-analysis in patients with class I to III obesity
CONCLUSIONS: . Although the data available in patients with class I obesity and type 2 diabetes remains limited, MA shows higher rates of DR after MS compared with MT after 36 months' follow-up in these patients. Consequently, the French National Authority for Health French (HAS) recommends MS for these patients.PMID:38000504 | DOI:10.1016/j.diabet.2023.101495 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 24, 2023 Category: Endocrinology Authors: Jean-Charles Lafarge Judith Aron-Wisnewsky Fran çois Pattou Michel Cucherat Emmanuelle Blondet Sylvie Lascols Armms Td Consortium Dominique Le Guludec Denis-Jean David C édric Carbonneil Source Type: research
Low frequency of albuminuria testing among diabetic patients in France: Real-world data from clinical laboratories
Diabetes Metab. 2023 Nov 23;50(1):101498. doi: 10.1016/j.diabet.2023.101498. Online ahead of print.NO ABSTRACTPMID:38000505 | DOI:10.1016/j.diabet.2023.101498 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 24, 2023 Category: Endocrinology Authors: Fabrice Bonnet L éa Longepierre Dinh-Phong Nguyen Im ène Sedrati Alegria Marcilla Source Type: research
Low frequency of albuminuria testing among diabetic patients in France: real-world data from clinical laboratories
Diabetes Metab. 2023 Nov 22:101498. doi: 10.1016/j.diabet.2023.101498. Online ahead of print.NO ABSTRACTPMID:38000505 | DOI:10.1016/j.diabet.2023.101498 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 24, 2023 Category: Endocrinology Authors: Fabrice Bonnet L éa Longepierre Dinh-Phong Nguyen Im ène Sedrati Alegria Marcilla Source Type: research
French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission- a meta-analysis in patients with class I to III obesity
CONCLUSIONS: . Although the data available in patients with class I obesity and type 2 diabetes remains limited, MA shows higher rates of DR after MS compared with MT after 36 months' follow-up in these patients. Consequently, the French National Authority for Health French (HAS) recommends MS for these patients.PMID:38000504 | DOI:10.1016/j.diabet.2023.101495 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 24, 2023 Category: Endocrinology Authors: Jean-Charles Lafarge Judith Aron-Wisnewsky Fran çois Pattou Michel Cucherat Emmanuelle Blondet Sylvie Lascols Armms Td Consortium Dominique Le Guludec Denis-Jean David C édric Carbonneil Source Type: research
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
CONCLUSION: This is the largest cross-sectional study showing that MASLD with and without coexisting significant fibrosis was associated, independently of potential confounders, with an increased risk of prevalent CKD and retinopathy in adults with T1DM.PMID:37992857 | DOI:10.1016/j.diabet.2023.101497 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 22, 2023 Category: Endocrinology Authors: Alessandro Mantovani Mario Luca Morieri Raffaella Aldigeri Luisa Palmisano Maria Masulli Katia Bonomo Marco Giorgio Baroni Efisio Cossu Flavia Agata Cimini Gisella Cavallo Raffaella Buzzetti Carmen Mignogna Frida Leonetti Simonetta Bacci Roberto Trevisan Source Type: research
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
CONCLUSION: This is the largest cross-sectional study showing that MASLD with and without coexisting significant fibrosis was associated, independently of potential confounders, with an increased risk of prevalent CKD and retinopathy in adults with T1DM.PMID:37992857 | DOI:10.1016/j.diabet.2023.101497 (Source: Diabetes and Metabolism)
Source: Diabetes and Metabolism - November 22, 2023 Category: Endocrinology Authors: Alessandro Mantovani Mario Luca Morieri Raffaella Aldigeri Luisa Palmisano Maria Masulli Katia Bonomo Marco Giorgio Baroni Efisio Cossu Flavia Agata Cimini Gisella Cavallo Raffaella Buzzetti Carmen Mignogna Frida Leonetti Simonetta Bacci Roberto Trevisan Source Type: research
